Screener
Adaptive Biotechnologies ADPT Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:30 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206546
FAQ
- What is Adaptive Biotechnologies's deferred tax assets and other non-current assets?
- Adaptive Biotechnologies (ADPT) reported deferred tax assets and other non-current assets of $1.24M in Q1 2026.
- How has Adaptive Biotechnologies's deferred tax assets and other non-current assets changed year-over-year?
- Adaptive Biotechnologies's deferred tax assets and other non-current assets decreased by 34.4% year-over-year, from $1.89M to $1.24M.
- What is the long-term trend for Adaptive Biotechnologies's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Adaptive Biotechnologies's deferred tax assets and other non-current assets has grown at a 15.1% compound annual growth rate (CAGR), from $598K to $1.21M.
Ask your AI about Adaptive Biotechnologies's deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude